EUVIMEDEUVIMED entdecken
Crossref

Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog

Kato Bredael iD, Martina Hrast Rambaher iD, Lena Decuyper, Katarina Magdalenic, Stanislav Gobec, Matthias D'hooghe iD

Chemistry – An Asian Journal · 2026-07 · 21 (13)

DOI: 10.1002/asia.70863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 06.07.2026. Verfasst von Kato Bredael und 5 weiteren Autor:innen. Beteiligte Einrichtung: SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Cephalosporins, Anti-Bacterial Agents. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Ghent University, FWO, Research Foundation-Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a major and growing global health challenge, necessitating the development of novel antibacterial agents. Previous in‐house research identified monocyclic α‐benzylidene‐substituted 3‐amino‐1‐carboxymethyl‐β‐lactams as promising hit scaffolds due to their potential to inhibit penicillin‐binding proteins (PBPs). In this study, a new ceftobiprole analog was designed by combining the characteristic α‐alkylidene fragment from this hit scaffold with the ceftobiprole vinylpyrrolidinone side chain selected for its favorable pharmacological properties. The target structure was synthesized via a modular approach, employing two Wittig reactions as key steps. Biochemical evaluation revealed that the ethyl ester derivative exhibited significant inhibition of S. pneumoniae PBP1b, highlighting this new framework as a valuable starting point for further optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsAnti-Bacterial AgentsPenicillin-Binding ProteinsMicrobial Sensitivity TestsStreptococcus pneumoniaeMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

PBP inhibitionWittig reactionantibacterial activityceftobiprolemonocyclic β‐lactams

Substanzen

CephalosporinsceftobiproleAnti-Bacterial AgentsPenicillin-Binding Proteins

Autor:innen und Institutionen

  • SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Kato Bredael, Martina Hrast Rambaher, Matthias D'hooghe

Förderung

  • Ghent University, FWO
  • Research Foundation-Flanders

Zitieren

APA

Bredael, K., Hrast Rambaher, M., Decuyper, L., Magdalenic, K., Gobec, S., & D'hooghe, M. (2026). Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog. Chemistry – An Asian Journal, 21(13). https://doi.org/10.1002/asia.70863

Vancouver

Bredael K, Hrast Rambaher M, Decuyper L, Magdalenic K, Gobec S, D'hooghe M. Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog. Chemistry – An Asian Journal. 2026;21(13). doi:10.1002/asia.70863

BibTeX
@article{Bredael2026,
  author = {Bredael, Kato and Hrast Rambaher, Martina and Decuyper, Lena and Magdalenic, Katarina and Gobec, Stanislav and D'hooghe, Matthias},
  title = {Development of a 3‐Amino‐1‐carboxymethyl‐β‐lactam‐Based Monocyclic Ceftobiprole Analog},
  journal = {Chemistry – An Asian Journal},
  year = {2026},
  volume = {21},
  number = {13},
  doi = {10.1002/asia.70863}
}
Kostenlos starten →